Prostate: Management Options Flashcards

1
Q

When is active surveillance used as an option?

A
  • Only in T1 and T2 stage cancers

- Localised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is active surveillance?

A
  • Monitors disease for low or intermediate risk
  • Can only be on active surveillance if they are eligible for radical treatment in the future
  • Can avoid or delay the surgery/treatment
  • Regular PSA tests, MRI and biopsies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is watchful waiting?

A
  • Aim is to control rather than to cure
  • for patients who are ineligible for radical treatment
  • Involves deferred use of hormone therapy
  • Less regular monitoring than active surveillance often via a GP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the disadvantages of watchful waiting/active surveillance?

A
  • If fast growing, then may not be eligible for radical treatment
  • Biopsies can lead to infection and side effects
  • General health may deteriorate
  • Anxiety
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a radical prostatectomy?

A
  • Removal of the entire prostate gland

- Laparoscopic surgery, robotic assisted or open surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the side effects of a radical prostatectomy?

A
  • Urinary leakage/incontinence
  • Erectile dysfunction
  • <5% of patients will develop acute urinary retention which is a medical emergency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Who is offered a radical prostatectomy?

A
  • Localised prostate cancers (T1 and T2)

- Patients with locally advanced prostate cancer are not usually offered the surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is radiotherapy used to treat prostate cancer?

A
  • Image guided IMRT or Vmat
  • Convention = 74-78Gy in approx 39# in 7.5 weeks
  • CHHiP trial changed to 60Gy in 20#s in 4 weeks
  • High risk localised post-surgery = 66Gy in 33#
  • Nodal 55-60Gy in 37#
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What pre-treatment radiotherapy preparation might be used?

A
  • Microenema to empty rectum

- Full bladder e.g. 3 cups in 20 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why are rectal spacers used?

A
  • SpaceOAR to reduce bowel side effects by moving rectum out of the high dose region
  • Made witha hydrogel liquid inserted through perineum under anaesthetic
  • remains there for three months then is naturally absorbed by the body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the acute side effects of radiotherapy?

A
  • Cystitis, nocturia or retention
  • Radiation proctitis (diarrhoea, tenesmus, urgency, rectal bleeding)
  • Radiaiton enteritis ( abdominal pain, bloating, nausea/vomiting, diarrhoea)
  • Fatigue
  • Sexual dysfuntion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are late effects of radiotherapy?

A
  • Urinary symptoms
  • Faecal incontinence
  • Sexual dysfunction
  • Pelvic radiation disease
  • Usually said to be 3 months later
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When is brachytherapy used to treat prostate cancer?

A
  • Used to achieve dose escalation
  • Used for localised prostate cancer, T1 and T2
  • Can also be used as a boost in T3 patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When is hormone therapy used to treat prostate cancer?

A
  • It is not curative

- Used adjuvant or neoadjuvantly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does hormonal therapy work?

A
  • ADT or androgen deprivation therapy reduces the level of androgens (testosterone) produced
  • These are injected or implanted LHRH agonists or LHRH/GnRH antagonists
  • Anti-Androgen drugs can block the effects of androgens on prostate cancer cells, these are in tablet form
  • Could remove testicles to reduce testosterone too
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How long are hormones typically taken?

A
  • 3-6 months before RT, during or after
  • Up to three years after treatment
  • Can be lifelong in advanced cancers
17
Q

What are the side effects of hormone therapy?

A
  • Hot flushes
  • Fatigue
  • Mood Changes
  • Alopecia
  • Osteoporosis (bisohosphonates can be given)
  • Cognitive issues
  • Sexual Dysfunction
  • Penis shortening
  • Weight gain
  • Breast swelling/tenderness
  • Reduces strength and muscle mass
18
Q

When is chemotherapy combined with hormone therapy?

A
  • In advanced metastatic prostate cancer
  • STAMPEDE Trial
  • Chemo within 12 weeks of radiotherapy
  • Dependent on patient fitness
19
Q

What options are there for metastatic prostate cancer?

A
  • Docetaxel chemo + hormone (STAMPEDE)
  • Hormone alone
  • RT ( no evidence that improved lifespan, but improved length of time without disease) 36Gy in 6 weeks
20
Q

What is hormone-relapsed/resistant prostate cancer?

A
  • Return of disease after hormone therapy
21
Q

How does hormone-relapsed/resistant prostate cancer typically get treated?

A
  • Anti-androgen tablets: Bicalutaminde (casodex)
  • Sometimes in combi with LHRH agonist injection = combined androgen blockade
  • Abiraterone
  • Could have docetaxel chemo if they have not had it before
  • Radium-223 injections to kill bone mets
  • oestrogen tablets, rarer
22
Q

What is the follow up procedure for prostate cancer?

A
  • Follow up at 6-8 weeks, 12 weeks, six months
  • PSA levels should be checked at six weeks then every six months and following that, once a year
  • After six months, stable PSA = remote follow up
23
Q

What is HIFU?

A
  • High-intensity Focused Ultrasound
  • New treatment
  • Treats whole or local prostate area
  • Low or intermediate risk locally advanced cases
  • Not suitable for men with a large prostate
  • Similar side effects to current treatment options
24
Q

How does cryotherapy work for prostate cancer?

A
  • Uses extreme cold
  • Whole focal or salvage
  • Localised low and intermediate cancers